Nevertheless, all analyzed mutations have an inhibitory effect on PTPN13 activity, and their presence appears to be associated with poor prognosis in lung cancer (p = 0.02) [128] and possibly in gastric cancer [141]. This evidence concerns the gene PTPN13 and lung carcinoma.